Mark D. Metzl

ORCID: 0000-0002-4053-597X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Arrhythmias and Treatments
  • Cardiac pacing and defibrillation studies
  • Cardiac electrophysiology and arrhythmias
  • Cardiac Valve Diseases and Treatments
  • Cardiac Imaging and Diagnostics
  • Cardiomyopathy and Myosin Studies
  • Venous Thromboembolism Diagnosis and Management
  • Cardiovascular Syncope and Autonomic Disorders
  • Healthcare Technology and Patient Monitoring
  • Cardiac Structural Anomalies and Repair
  • Pericarditis and Cardiac Tamponade
  • Health Systems, Economic Evaluations, Quality of Life
  • Respiratory Support and Mechanisms
  • Infective Endocarditis Diagnosis and Management
  • Quality and Safety in Healthcare
  • Cardiovascular Function and Risk Factors
  • Mechanical Circulatory Support Devices
  • Cardiac Arrest and Resuscitation
  • Sarcoidosis and Beryllium Toxicity Research
  • Trauma Management and Diagnosis
  • Aerodynamics and Fluid Dynamics Research
  • Thermal Regulation in Medicine
  • Tissue Engineering and Regenerative Medicine
  • Mitochondrial Function and Pathology

NorthShore University HealthSystem
2016-2025

University of Chicago Medical Center
2025

University of Chicago
2011-2024

Evanston Hospital
2020-2024

North Shore University Hospital
2024

Endeavor Charter School
2024

Swedish Covenant Hospital
2024

Clinical Research Solutions
2024

University of Illinois Chicago
2024

The University of Texas Southwestern Medical Center
2022-2023

Active esophageal cooling reduces the incidence of endoscopically identified severe lesions during radiofrequency (RF) catheter ablation left atrium for treatment atrial fibrillation. A formal analysis atrioesophageal fistula (AEF) rate with active has not previously been performed.

10.1016/j.jacep.2023.08.022 article EN cc-by JACC. Clinical electrophysiology 2023-09-20

Abstract Background Active esophageal cooling during pulmonary vein isolation (PVI) with radiofrequency (RF) ablation for the treatment of atrial fibrillation (AF) is increasingly being utilized to reduce injury and atrioesophageal fistula formation. Randomized controlled data also show trends towards increased freedom from AF when using active cooling. This study aimed compare 1-year arrhythmia recurrence rates between patients treated luminal temperature (LET) monitoring versus left...

10.1007/s10840-023-01474-3 article EN cc-by Journal of Interventional Cardiac Electrophysiology 2023-01-21

Inactivation of the transcription factor p53 is central to carcinogenesis. Yet only approximately one-half cancers have loss-of-function mutations. Here, we demonstrate a mechanism for inactivation by apoptosis repressor with caspase recruitment domain (ARC), protein induced in multiple cancer cells. The direct binding nucleus ARC tetramerization inhibits tetramerization. This exposes nuclear export signal p53, triggering Crm1-dependent relocation cytoplasm. Knockdown endogenous breast cells...

10.1073/pnas.0710017104 article EN Proceedings of the National Academy of Sciences 2007-12-18

During atrial fibrillation ablation (AFA), achievement of first pass isolation (FPI) reflects effective lesion formation and predicts long-term freedom from arrhythmia recurrence. We aim to determine the clinical procedural predictors pulmonary vein FPI.

10.1111/jce.16190 article EN Journal of Cardiovascular Electrophysiology 2024-01-28

Radiofrequency (RF) ablation to perform pulmonary vein isolation (PVI) for the treatment of atrial fibrillation involves some risk collateral structures, including esophagus. Proactive esophageal cooling using a dedicated device has been granted marketing authorization by Food and Drug Administration (FDA) reduce ablation-related injury due RF cardiac procedures, more recent data also suggest that may contribute improved long-term efficacy treatment. A mechanistic underpinning explaining...

10.3791/66688 article EN Journal of Visualized Experiments 2024-04-19

ABSTRACT Severe tricuspid regurgitation (TR) is associated with significant morbidity and mortality. Management of severe TR includes treatment the underlying cause(s), medical therapy less commonly surgical valve repair. Newer transcatheter repair devices show promise for those patients who remain symptomatic despite such efforts. The presence a Cardiac Implantable Electronic Device (CIED) leads across poses challenge from both diagnostic therapeutic standpoints. In this paper, we propose...

10.1002/ccd.31444 article EN cc-by-nc Catheterization and Cardiovascular Interventions 2025-02-28

For evaluation of the pulmonary arteries in patients suspected embolism, CT angiography (CTA) is first-line imaging test with contrast-enhanced MR (CEMRA) a potential alternative. Disadvantages CTA include exposure to ionizing radiation and an iodinated contrast agent, while CEMRA sensitive respiratory motion requires gadolinium-based agent. The primary goal our technical feasibility study was evaluate arterial conspicuity using breath-hold free-breathing implementations recently-developed...

10.1186/s12968-017-0365-3 article EN cc-by Journal of Cardiovascular Magnetic Resonance 2016-12-01

Active esophageal cooling is increasingly utilized as an alternative to luminal temperature (LET) monitoring for protection against thermal injury during pulmonary vein isolation (PVI) when treating atrial fibrillation (AF). Published data demonstrate the efficacy of active in reducing injury, but impacts on procedural efficiency are not well characterized. LET compels pauses ablation due heat stacking and overheating alarms that turn delay progress PVI procedure, whereas allows avoidance...

10.1007/s10840-022-01204-1 article EN cc-by Journal of Interventional Cardiac Electrophysiology 2022-04-13
Coming Soon ...